A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients with Myeloid Malignancies

  • Teh, Tse-Chieh (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date5/05/21 → 31/12/26

Keywords

  • Myeloid Malignancies
  • Blood disorders
  • Clinical trial

Clinical Trial Phase

  • Phase I
  • Phase II